• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在单独使用和联合使用溴莫尼定及噻吗洛尔治疗的正常人类眼睛中房水的流动情况。

Aqueous humor flow in normal human eyes treated with brimonidine and timolol, alone and in combination.

作者信息

Larsson L I

机构信息

Department of Ophthalmology, Uppsala University Hospital, S-751 85 Uppsala, Sweden.

出版信息

Arch Ophthalmol. 2001 Apr;119(4):492-5. doi: 10.1001/archopht.119.4.492.

DOI:10.1001/archopht.119.4.492
PMID:11296014
Abstract

OBJECTIVE

To compare the effect on aqueous humor flow and intraocular pressure (IOP) of topically applied 0.2% brimonidine tartrate with topically administered 0.5% timolol maleate, alone and in combination.

DESIGN

A randomized, double-masked, placebo-controlled study of 20 human subjects was carried out. The topical drugs were instilled twice daily the day before and again on the morning of the day of the measurements. Aqueous humor flow was measured by clearance of topically applied fluorescein with a fluorophotometer, and IOP was measured with an applanation tonometer.

RESULTS

Brimonidine reduced the aqueous humor flow by 33.1%; timolol, by 49.9%; and the combination of brimonidine and timolol, by 58.9%. Brimonidine reduced the IOP by 20.3%; timolol, by 22.9%; and the combination of brimonidine and timolol, by 34.7%.

CONCLUSIONS

Brimonidine suppressed aqueous humor flow, but not as effectively as timolol. However, the effects on the IOP of both drugs separately were comparable. The short-term effect of brimonidine was partly additive to timolol, and the combination treatment caused a further reduction in aqueous humor flow and IOP. The IOP reduction by timolol could be explained solely by aqueous humor flow reduction. Much of the IOP reduction caused by brimonidine, but not all, could be explained by suppression of the aqueous humor flow, suggesting an additional mechanism for the ocular hypotensive effect of brimonidine.

摘要

目的

比较局部应用0.2%酒石酸溴莫尼定与局部应用0.5%马来酸噻吗洛尔单独及联合使用对房水流出和眼压(IOP)的影响。

设计

对20名人类受试者进行了一项随机、双盲、安慰剂对照研究。在测量前一天每天两次滴注局部用药,测量当天上午再次滴注。用荧光光度计通过局部应用荧光素的清除率测量房水流出,用压平眼压计测量眼压。

结果

溴莫尼定使房水流出减少33.1%;噻吗洛尔使房水流出减少49.9%;溴莫尼定与噻吗洛尔联合使用使房水流出减少58.9%。溴莫尼定使眼压降低20.3%;噻吗洛尔使眼压降低22.9%;溴莫尼定与噻吗洛尔联合使用使眼压降低34.7%。

结论

溴莫尼定抑制房水流出,但效果不如噻吗洛尔。然而,两种药物单独对眼压的影响相当。溴莫尼定的短期作用与噻吗洛尔部分相加,联合治疗使房水流出和眼压进一步降低。噻吗洛尔降低眼压可仅通过房水流出减少来解释。溴莫尼定引起的眼压降低大部分(但不是全部)可通过抑制房水流出解释,提示溴莫尼定降眼压作用存在额外机制。

相似文献

1
Aqueous humor flow in normal human eyes treated with brimonidine and timolol, alone and in combination.在单独使用和联合使用溴莫尼定及噻吗洛尔治疗的正常人类眼睛中房水的流动情况。
Arch Ophthalmol. 2001 Apr;119(4):492-5. doi: 10.1001/archopht.119.4.492.
2
Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents.溴莫尼定与阿可乐定作为局部降眼压药物的早期效果比较。
Arch Ophthalmol. 1999 May;117(5):586-91. doi: 10.1001/archopht.117.5.586.
3
Aqueous humor flow in normal human eyes treated with brimonidine and dorzolamide, alone and in combination.单独及联合使用溴莫尼定和多佐胺治疗的正常人眼中房水的流动情况。
Arch Ophthalmol. 2004 Feb;122(2):190-3. doi: 10.1001/archopht.122.2.190.
4
Effects of brimonidine on aqueous humor dynamics in human eyes.溴莫尼定对人眼房水动力学的影响。
Arch Ophthalmol. 1995 Dec;113(12):1514-7. doi: 10.1001/archopht.1995.01100120044006.
5
Comparison of the efficacy of apraclonidine and brimonidine as aqueous suppressants in humans.阿可乐定与溴莫尼定作为人类房水生成抑制剂的疗效比较。
Arch Ophthalmol. 1998 Nov;116(11):1441-4. doi: 10.1001/archopht.116.11.1441.
6
Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2.一项正在进行的随机试验的12个月结果,该试验比较了0.2%酒石酸溴莫尼定和0.5%噻吗洛尔每日两次给药于青光眼或高眼压症患者的疗效。溴莫尼定研究组2。
Ophthalmology. 1998 Oct;105(10):1960-7. doi: 10.1016/s0161-6420(98)91048-x.
7
Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension.0.2%溴莫尼定与0.5%噻吗洛尔治疗青光眼和高眼压症的临床经验。
Surv Ophthalmol. 1996 Nov;41 Suppl 1:S27-37. doi: 10.1016/s0039-6257(96)82029-7.
8
A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group.溴莫尼定每日两次治疗青光眼和高眼压症的1年研究。一项对照、随机、多中心临床试验。慢性溴莫尼定研究组。
Arch Ophthalmol. 1997 Jul;115(7):847-52. doi: 10.1001/archopht.1997.01100160017002.
9
Assessment of ocular hypotensive mechanisms and additivity of antiglaucoma drugs in humans.人体眼压降低机制及抗青光眼药物相加作用的评估。
Arch Ophthalmol. 1999 May;117(5):673-4. doi: 10.1001/archopht.117.5.673.
10
Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol. Brimonidine Study Groups 1 and 2.全身性β受体阻滞剂疗法对局部用溴莫尼定和噻吗洛尔疗效及安全性的影响。溴莫尼定研究组1和研究组2。
Ophthalmology. 2000 Jun;107(6):1171-7. doi: 10.1016/s0161-6420(00)00081-6.

引用本文的文献

1
Inhibitory and Agonistic Autoantibodies Directed Against the β-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma.针对假性剥脱综合征和青光眼患者β-肾上腺素能受体的抑制性和激动性自身抗体
Front Neurosci. 2021 Aug 6;15:676579. doi: 10.3389/fnins.2021.676579. eCollection 2021.
2
Effect of Timolol on Aqueous Humor Outflow Facility in Healthy Human Eyes.噻吗洛尔对正常人眼房水流畅系数的影响。
Am J Ophthalmol. 2019 Jun;202:126-132. doi: 10.1016/j.ajo.2019.02.014. Epub 2019 Feb 19.
3
Agonistic Autoantibodies to the β2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma.
β2-肾上腺素能受体激动性自身抗体与开角型青光眼发病机制有关。
Front Immunol. 2018 Feb 12;9:145. doi: 10.3389/fimmu.2018.00145. eCollection 2018.
4
Intraocular pressure reduction using a fixed combination of timolol maleate 0.5% and brimonidine tartrate 0.2% administered three times daily.使用0.5%马来酸噻吗洛尔和0.2%酒石酸溴莫尼定的固定复方制剂,每日给药三次降低眼压。
Clin Ophthalmol. 2013;7:1269-73. doi: 10.2147/OPTH.S47760. Epub 2013 Jun 25.
5
A contemporary concept of the blood-aqueous barrier.当代血-房水屏障概念。
Prog Retin Eye Res. 2013 Jan;32:181-95. doi: 10.1016/j.preteyeres.2012.10.004. Epub 2012 Nov 2.
6
Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure.用于青光眼和眼压控制不佳的0.2%酒石酸溴莫尼定与0.5%噻吗洛尔的固定复方制剂
Clin Ophthalmol. 2008 Sep;2(3):545-55. doi: 10.2147/opth.s3840.
7
Topical brimonidine 0.2%/timolol 0.5% ophthalmic solution: in glaucoma and ocular hypertension.0.2%酒石酸溴莫尼定/0.5%噻吗洛尔滴眼液:用于青光眼和高眼压症。
Drugs Aging. 2006;23(9):753-61. doi: 10.2165/00002512-200623090-00005.